Chronic obstructive pulmonary disease (COPD) – patient‘s perspective

S. Faruqi, I. Djoukhadar, M. Thirumaran, V. Balliga, S. Meghjee (Wakefield, West Yorkshire, United Kingdom)

Source: Annual Congress 2007 - Smoking and the lung
Session: Smoking and the lung
Session type: Thematic Poster Session
Number: 1063
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Faruqi, I. Djoukhadar, M. Thirumaran, V. Balliga, S. Meghjee (Wakefield, West Yorkshire, United Kingdom). Chronic obstructive pulmonary disease (COPD) – patient‘s perspective. Eur Respir J 2007; 30: Suppl. 51, 1063

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Therapeutic approaches in the chronic obstructive (COPD) pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 472s
Year: 2002

Chronic obstructive pulmonary disease (COPD) in children: is it possible?
Source: Eur Respir J 2005; 26: Suppl. 49, 63s
Year: 2005

Awareness of chronic obstructive pulmonary disease (COPD) in Portugal
Source: Eur Respir J 2007; 30: Suppl. 51, 126s
Year: 2007

Chronic obstructive pulmonary disease: the patient perspective
Source: Eur Respir J 2001; 18: Suppl. 33, 401s
Year: 2001

Accelerated ageing and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2003 - Cigarette smoke: how it does its dirty work
Year: 2003


The evaluation of a helpline for chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2004 - Smoking and cessation in respiratory disease
Year: 2004


Periodontitis and chronic obstructive pulmonary disease
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006


Chronic obstructive pulmonary disease (COPD) patients with bronchiectasis: clinical features?
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018


Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2013; 62: 1-18
Year: 2013


Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2014; 65: 1-17
Year: 2014


Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2015; 70: 80-98
Year: 2015


Chronic obstructive pulmonary disease
Source: Eur Respir Mon; 2009: 45: 25–31
Year: 2009

Acute effects of sildenafil in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008

Functional illiteracy amongst those with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 57s
Year: 2005

The state of patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 547s
Year: 2007

Optimal assessment and management of chronic obstructive pulmonary disease (COPD)
Source: Guideline 1995
Year: 1995

Correlates of osteoporosis in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010

Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


The impact of using different symptom-based exacerbation algorithms in patients with COPD
Source: Eur Respir J 2011; 37: 1260-1268
Year: 2011



Prevalence of chronic obstructive pulmonary disease (COPD) in Greece
Source: Eur Respir J 2002; 20: Suppl. 38, 122s
Year: 2002